Team:Yale/Project/MAGE
From 2011.igem.org
(Difference between revisions)
Line 11: | Line 11: | ||
Gel confirming success of PCR reactions for eventual crossover PCR. 1: 1kb ladder, 2: 1 kb ladder, 3: 100 bp ladder, 4: did not work - AR7 (supposed to be RiAFP gene only with 78 integration site and Kan crossover site), 5: did not work - replicate of above, 6: worked: AR14 ii - (RiAFP with 141 integration site and Kan crossover site)<br /><img src="https://static.igem.org/mediawiki/2011/a/a6/Mage7.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br />Gels confirming success of crossover PCR for lambda red integration.1: ladder:, 2: GR7 + 78 kan (failed), 3: replicate, 4: replicate, 5: GR14 + 141 Kan (worked), 6: replicate, 7: replicate, 8: AR14 + 141 Kan (worked), 9: replicate, 10: replicate, 11: replicate<br /><br /> | Gel confirming success of PCR reactions for eventual crossover PCR. 1: 1kb ladder, 2: 1 kb ladder, 3: 100 bp ladder, 4: did not work - AR7 (supposed to be RiAFP gene only with 78 integration site and Kan crossover site), 5: did not work - replicate of above, 6: worked: AR14 ii - (RiAFP with 141 integration site and Kan crossover site)<br /><img src="https://static.igem.org/mediawiki/2011/a/a6/Mage7.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br />Gels confirming success of crossover PCR for lambda red integration.1: ladder:, 2: GR7 + 78 kan (failed), 3: replicate, 4: replicate, 5: GR14 + 141 Kan (worked), 6: replicate, 7: replicate, 8: AR14 + 141 Kan (worked), 9: replicate, 10: replicate, 11: replicate<br /><br /> | ||
The lambda-red recombination of the AFP-Kan and AFP-eGFP-Kan in the EcNR2 strain worked; there were colonies on the appropriate Kanamycin plates and no colonies on the -ve control Kanamycin plates (no DNA added for electroporation). See below for sample colony plates (top row, negative control plates with no colonies; bottom row left plate with colonies of RiAFP-GFP-Kanamycin ; bottom row right plate with colonies of RiAFP-Kanamycin<br /><img src="https://static.igem.org/mediawiki/2011/2/29/Mage8.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | The lambda-red recombination of the AFP-Kan and AFP-eGFP-Kan in the EcNR2 strain worked; there were colonies on the appropriate Kanamycin plates and no colonies on the -ve control Kanamycin plates (no DNA added for electroporation). See below for sample colony plates (top row, negative control plates with no colonies; bottom row left plate with colonies of RiAFP-GFP-Kanamycin ; bottom row right plate with colonies of RiAFP-Kanamycin<br /><img src="https://static.igem.org/mediawiki/2011/2/29/Mage8.jpg" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | ||
- | We designed and ordered 22 degenerate oligos to target the theorized ice-binding site of RiAFP. These oligos were designed to insert additional Tx repeats, delete Tx repeats, delete entire TxT segments, and replace regions with degenerate TxTxTxT repeats. | + | </div> |
+ | <div id="container"> | ||
+ | <h1>Design and modeling of degenerate oligonucleotides</h1> | ||
+ | We designed and ordered 22 degenerate oligos to target the theorized ice-binding site of RiAFP. These oligos were designed to insert additional Tx repeats, delete Tx repeats, delete entire TxT segments, and replace regions with degenerate TxTxTxT repeats. The specific MAGE oligos and design methodology can be found in <a href="https://static.igem.org/mediawiki/2011/e/e6/IGEM_--_MAGE_Oligos.pdf">this document</a><br /><br /> | ||
+ | To model the recombination mutation frequency of these oligos, we first considered the degeneracy and subsequent complexity of the entire set of 22 oligos: | ||
+ | <img src="https://static.igem.org/mediawiki/2011/0/0d/Oligocomplexity.png" style="margin-top:10px; margin-bottom:10px; margin-left:auto; margin-right:auto; display:block;" /><br /> | ||
+ | |||
+ | </div> | ||
Thus far, we have generated a diverse population of mutants for the antifreeze protein sequence. Based on data from the original MAGE paper, we have generated four hundred and thirty four million predicted genomic variants thus far. An average change of 0.62 bp per cell across the population is detected after one MAGE cycles, multiplied by 7x108 cells across the cell population. This represents more potential “biobricks” than currently exist in the iGEM registry, generated in one experiment! We are currently applying the selective pressure of multiple freeze thaw cycles. We intend to run additional MAGE cycles on mutants that survive multiple freeze thaw cycles to hopefully generate and then characterize “superactive”, soluble antifreeze proteins. | Thus far, we have generated a diverse population of mutants for the antifreeze protein sequence. Based on data from the original MAGE paper, we have generated four hundred and thirty four million predicted genomic variants thus far. An average change of 0.62 bp per cell across the population is detected after one MAGE cycles, multiplied by 7x108 cells across the cell population. This represents more potential “biobricks” than currently exist in the iGEM registry, generated in one experiment! We are currently applying the selective pressure of multiple freeze thaw cycles. We intend to run additional MAGE cycles on mutants that survive multiple freeze thaw cycles to hopefully generate and then characterize “superactive”, soluble antifreeze proteins. | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 15:53, 28 October 2011